[go: up one dir, main page]

HK1198389B - 增强的干细胞组合物 - Google Patents

增强的干细胞组合物 Download PDF

Info

Publication number
HK1198389B
HK1198389B HK14111892.0A HK14111892A HK1198389B HK 1198389 B HK1198389 B HK 1198389B HK 14111892 A HK14111892 A HK 14111892A HK 1198389 B HK1198389 B HK 1198389B
Authority
HK
Hong Kong
Prior art keywords
cells
pge
cell
contacted
hspcs
Prior art date
Application number
HK14111892.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1198389A1 (zh
Inventor
Dan Shoemaker
David Robbins
John D. Mendlein
Caroline Desponts
Original Assignee
Fate Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fate Therapeutics, Inc. filed Critical Fate Therapeutics, Inc.
Priority claimed from PCT/US2012/066987 external-priority patent/WO2013082243A1/en
Publication of HK1198389A1 publication Critical patent/HK1198389A1/zh
Publication of HK1198389B publication Critical patent/HK1198389B/zh

Links

HK14111892.0A 2011-12-02 2012-11-29 增强的干细胞组合物 HK1198389B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161566492P 2011-12-02 2011-12-02
US201161566492P 2011-12-02
PCT/US2012/066987 WO2013082243A1 (en) 2011-12-02 2012-11-29 Enhanced stem cell composition

Publications (2)

Publication Number Publication Date
HK1198389A1 HK1198389A1 (zh) 2015-04-17
HK1198389B true HK1198389B (zh) 2021-02-26

Family

ID=

Similar Documents

Publication Publication Date Title
US11052118B2 (en) Enhanced stem cell composition
US10980838B2 (en) Methods of treating ischemia
HK40047396A (zh) 增强的干细胞组合物
HK1198389B (zh) 增强的干细胞组合物
HK1201556B (zh) 增强的干细胞组合物